{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T05:24:41Z","timestamp":1732857881123,"version":"3.30.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,28]]},"DOI":"10.7759\/cureus.74670","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:20:21Z","timestamp":1732807221000},"source":"Crossref","is-referenced-by-count":0,"title":["Expression of Monocytes Subsets in Patients Diagnosed With Coronary Artery Atherosclerosis and Their Impact on Disease Severity"],"prefix":"10.7759","author":[{"given":"Asmaa Khalf","family":"Kamel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa M","family":"Farag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa Elzaeem","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-020-01362-4","article-title":"Periodic and intermittent fasting in diabetes and cardiovascular disease","volume":"20","author":"Crupi AN","year":"2020","unstructured":"Crupi AN, Haase J, Brandhorst S, Longo VD. Periodic and intermittent fasting in diabetes and cardiovascular disease. Curr Diab Rep. 2020, 20:83. 10.1007\/s11892-020-01362-4","journal-title":"Curr Diab Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413471","article-title":"Inflammation in coronary microvascular dysfunction","volume":"22","author":"Sagris M","year":"2021","unstructured":"Sagris M, Theofilis P, Antonopoulos AS, et al.. Inflammation in coronary microvascular dysfunction. Int J Mol Sci. 2021, 22:71. 10.3390\/ijms222413471","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2022.10.004","article-title":"Lipoprotein(a) and inflammation - pathophysiological links and clinical implications for cardiovascular disease","volume":"17","author":"Simantiris S","year":"2023","unstructured":"Simantiris S, Antonopoulos AS, Papastamos C, Benetos G, Koumallos N, Tsioufis K, Tousoulis D. Lipoprotein(a) and inflammation - pathophysiological links and clinical implications for cardiovascular disease. J Clin Lipidol. 2023, 17:55-63. 10.1016\/j.jacl.2022.10.004","journal-title":"J Clin Lipidol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in atherosclerosis regression","volume":"40","author":"Barrett TJ","year":"2020","unstructured":"Barrett TJ. Macrophages in atherosclerosis regression. Arterioscler Thromb Vasc Biol. 2020, 40:20-33. 10.1161\/ATVBAHA.119.312802","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.640124","article-title":"The association between monocyte subsets and cardiometabolic disorders\/cardiovascular disease: a systematic review and meta-analysis","volume":"8","author":"Oh ES","year":"2021","unstructured":"Oh ES, Na M, Rogers CJ. The association between monocyte subsets and cardiometabolic disorders\/cardiovascular disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2021, 8:640124. 10.3389\/fcvm.2021.640124","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1105-0","article-title":"Physiology-guided management of serial\/diffuse coronary artery disease","volume":"21","author":"Murray CS","year":"2019","unstructured":"Murray CS, Siddiqui T, Keller N, Chowdhury S, Nahar T. Physiology-guided management of serial\/diffuse coronary artery disease. Curr Cardiol Rep. 2019, 21:25. 10.1007\/s11886-019-1105-0","journal-title":"Curr Cardiol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105812","article-title":"Lipoprotein(a): knowns, unknowns and uncertainties","volume":"173","author":"Ruscica M","year":"2021","unstructured":"Ruscica M, Sirtori CR, Corsini A, Watts GF, Sahebkar A. Lipoprotein(a): knowns, unknowns and uncertainties. Pharmacol Res. 2021, 173:105812. 10.1016\/j.phrs.2021.105812","journal-title":"Pharmacol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2019.03.004","article-title":"Lipoprotein(a): an independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction","volume":"71","author":"Enas EA","year":"2019","unstructured":"Enas EA, Varkey B, Dharmarajan TS, Pare G, Bahl VK. Lipoprotein(a): an independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Indian Heart J. 2019, 71:99-112. 10.1016\/j.ihj.2019.03.004","journal-title":"Indian Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa247","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"67","author":"Kamstrup PR","year":"2021","unstructured":"Kamstrup PR. Lipoprotein(a) and cardiovascular disease. Clin Chem. 2021, 67:154-66. 10.1093\/clinchem\/hvaa247","journal-title":"Clin Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0051","article-title":"Lipoprotein(a) and cardiovascular diseases - revisited","volume":"84","author":"Jang AY","year":"2020","unstructured":"Jang AY, Han SH, Sohn IS, Oh PC, Koh KK. Lipoprotein(a) and cardiovascular diseases - revisited. Circ J. 2020, 84:867-74. 10.1253\/circj.CJ-20-0051","journal-title":"Circ J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2018.06.003","article-title":"The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era","volume":"60","author":"Nakas G","year":"2019","unstructured":"Nakas G, Bechlioulis A, Marini A, et al.. The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era. Hellenic J Cardiol. 2019, 60:241-6. 10.1016\/j.hjc.2018.06.003","journal-title":"Hellenic J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong P","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022, 7:131. 10.1038\/s41392-022-00955-7","journal-title":"Signal Transduct Target Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.47998","article-title":"Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis","volume":"17","author":"Xiang Y","year":"2020","unstructured":"Xiang Y, Liang B, Zhang X, Zheng F. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis. Int J Med Sci. 2020, 17:2171-9. 10.7150\/ijms.47998","journal-title":"Int J Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179119","article-title":"Nature versus number: monocytes in cardiovascular disease","volume":"22","author":"Williams H","year":"2021","unstructured":"Williams H, Mack CD, Li SC, Fletcher JP, Medbury HJ. Nature versus number: monocytes in cardiovascular disease. Int J Mol Sci. 2021, 22:9119. 10.3390\/ijms22179119","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017108","article-title":"Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: a cohort study","volume":"98","author":"Charach G","year":"2019","unstructured":"Charach G, Rogowski O, Karniel E, Charach L, Grosskopf I, Novikov I. Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: a cohort study. Medicine (Baltimore). 2019, 98:e17108. 10.1097\/MD.0000000000017108","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11508","article-title":"Utility of routine laboratory tests in the assessment of chronic venous disease progression in female patients","volume":"24","author":"Matei SC","year":"2022","unstructured":"Matei SC, Matei M, Anghel FM, Carabenciov E, Murariu MS, Olariu S. Utility of routine laboratory tests in the assessment of chronic venous disease progression in female patients. Exp Ther Med. 2022, 24:571. 10.3892\/etm.2022.11508","journal-title":"Exp Ther Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.315930","article-title":"Sex as a biological variable in atherosclerosis","volume":"126","author":"Man JJ","year":"2020","unstructured":"Man JJ, Beckman JA, Jaffe IZ. Sex as a biological variable in atherosclerosis. Circ Res. 2020, 126:1297-319. 10.1161\/CIRCRESAHA.120.315930","journal-title":"Circ Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-019-09555-4","article-title":"Platelet function in cardiovascular disease: activation of molecules and activation by molecules","volume":"20","author":"Khodadi E","year":"2020","unstructured":"Khodadi E. Platelet function in cardiovascular disease: activation of molecules and activation by molecules. Cardiovasc Toxicol. 2020, 20:1-10. 10.1007\/s12012-019-09555-4","journal-title":"Cardiovasc Toxicol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy169","article-title":"Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease","volume":"39","author":"Helgadottir A","year":"2018","unstructured":"Helgadottir A, Sulem P, Thorgeirsson G, et al.. Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease. Eur Heart J. 2018, 39:2172-8. 10.1093\/eurheartj\/ehy169","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00430","article-title":"C-reactive protein in atherothrombosis and angiogenesis","volume":"9","author":"Badimon L","year":"2018","unstructured":"Badimon L, Pe\u00f1a E, Arderiu G, Padr\u00f3 T, Slevin M, Vilahur G, Chiva-Blanch G. C-reactive protein in atherothrombosis and angiogenesis. Front Immunol. 2018, 9:430. 10.3389\/fimmu.2018.00430","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02610-z","article-title":"CRP levels are significantly associated with CRP genotype and estrogen use in The Lifestyle, Biomarker and Atherosclerosis (LBA) study","volume":"22","author":"Frans\u00e9n K","year":"2022","unstructured":"Frans\u00e9n K, Pettersson C, Hurtig-Wennl\u00f6f A. CRP levels are significantly associated with CRP genotype and estrogen use in The Lifestyle, Biomarker and Atherosclerosis (LBA) study. BMC Cardiovasc Disord. 2022, 22:170. 10.1186\/s12872-022-02610-z","journal-title":"BMC Cardiovasc Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.09.027","article-title":"Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals","volume":"349","author":"Lee H","year":"2022","unstructured":"Lee H, Park KS, Jeon YJ, et al.. Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals. Atherosclerosis. 2022, 349:190-5. 10.1016\/j.atherosclerosis.2021.09.027","journal-title":"Atherosclerosis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.044","article-title":"Association of lipoprotein(a) with atherosclerotic plaque progression","volume":"79","author":"Kaiser Y","year":"2022","unstructured":"Kaiser Y, Daghem M, Tzolos E, et al.. Association of lipoprotein(a) with atherosclerotic plaque progression. J Am Coll Cardiol. 2022, 79:223-33. 10.1016\/j.jacc.2021.10.044","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation","volume":"67","author":"Hoogeveen RC","year":"2021","unstructured":"Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation. Clin Chem. 2021, 67:143-53. 10.1093\/clinchem\/hvaa252","journal-title":"Clin Chem"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz784","article-title":"Gender in cardiovascular medicine: chest pain and coronary artery disease","volume":"40","author":"Mehta PK","year":"2019","unstructured":"Mehta PK, Bess C, Elias-Smale S, Vaccarino V, Quyyumi A, Pepine CJ, Bairey Merz CN. Gender in cardiovascular medicine: chest pain and coronary artery disease. Eur Heart J. 2019, 40:3819-26. 10.1093\/eurheartj\/ehz784","journal-title":"Eur Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8060063","article-title":"The association of lipoprotein(a) and circulating monocyte subsets with severe coronary atherosclerosis","volume":"8","author":"Afanasieva OI","year":"2021","unstructured":"Afanasieva OI, Filatova AY, Arefieva TI, et al.. The association of lipoprotein(a) and circulating monocyte subsets with severe coronary atherosclerosis. J Cardiovasc Dev Dis. 2021, 8:63. 10.3390\/jcdd8060063","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.616305","article-title":"Monocyte subset recruitment marker profile is inversely associated with blood ApoA1 levels","volume":"12","author":"Patel VK","year":"2021","unstructured":"Patel VK, Williams H, Li SC, Fletcher JP, Medbury HJ. Monocyte subset recruitment marker profile is inversely associated with blood ApoA1 levels. Front Immunol. 2021, 12:10. 10.3389\/fimmu.2021.616305","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12314","article-title":"The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes","volume":"82","author":"Idzkowska E","year":"2015","unstructured":"Idzkowska E, Eljaszewicz A, Miklasz P, Musial WJ, Tycinska AM, Moniuszko M. The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes. Scand J Immunol. 2015, 82:163-73. 10.1111\/sji.12314","journal-title":"Scand J Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7434376","article-title":"The role of monocytes and macrophages in human atherosclerosis, plaque neoangiogenesis, and atherothrombosis","volume":"4","author":"Moroni F","year":"2019","unstructured":"Moroni F, Ammirati E, Norata GD, Magnoni M, Camici PG. The role of monocytes and macrophages in human atherosclerosis, plaque neoangiogenesis, and atherothrombosis. Mediators Inflamm. 2019, 4:376. 10.1155\/2019\/7434376","journal-title":"Mediators Inflamm"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9852507","article-title":"Monocyte\/lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients","volume":"14","author":"Wen Y","year":"2020","unstructured":"Wen Y, Zhan X, Wang N, Peng F, Feng X, Wu X. Monocyte\/lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients. Mediators Inflamm. 2020, 14:507. 10.1155\/2020\/9852507","journal-title":"Mediators Inflamm"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.06.020","article-title":"Relation of plasma lipoprotein(a) to subclinical coronary plaque volumes, three-vessel and left main coronary disease, and severe coronary stenoses in apparently healthy African Americans with a family history of early-onset coronary artery disease","volume":"118","author":"Kral BG","year":"2016","unstructured":"Kral BG, Kalyani RR, Yanek LR, Vaidya D, Fishman EK, Becker DM, Becker LC. Relation of plasma lipoprotein(a) to subclinical coronary plaque volumes, three-vessel and left main coronary disease, and severe coronary stenoses in apparently healthy African Americans with a family history of early-onset coronary artery disease. Am J Cardiol. 2016, 118:656-61. 10.1016\/j.amjcard.2016.06.020","journal-title":"Am J Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.02.001","article-title":"Lipoprotein(a) and inflammation: a dangerous duet leading to endothelial loss of integrity","volume":"119","author":"Pirro M","year":"2017","unstructured":"Pirro M, Bianconi V, Paciullo F, Mannarino MR, Bagaglia F, Sahebkar A. Lipoprotein(a) and inflammation: a dangerous duet leading to endothelial loss of integrity. Pharmacol Res. 2017, 119:178-87. 10.1016\/j.phrs.2017.02.001","journal-title":"Pharmacol Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12883","article-title":"Pattern of human monocyte subpopulations in health and disease","volume":"92","author":"O\u017ca\u0144ska A","year":"2020","unstructured":"O\u017ca\u0144ska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020, 92:e12883. 10.1111\/sji.12883","journal-title":"Scand J Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong KL","year":"2011","unstructured":"Wong KL, Tai JJ, Wong WC, et al.. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011, 118:e16-31. 10.1182\/blood-2010-12-326355","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-326827","article-title":"SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset","volume":"118","author":"Zawada AM","year":"2011","unstructured":"Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, Heine GH. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood. 2011, 118:e50-61. 10.1182\/blood-2011-01-326827","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/308212-expression-of-monocytes-subsets-in-patients-diagnosed-with-coronary-artery-atherosclerosis-and-their-impact-on-disease-severity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:20:22Z","timestamp":1732807222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/308212-expression-of-monocytes-subsets-in-patients-diagnosed-with-coronary-artery-atherosclerosis-and-their-impact-on-disease-severity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.74670","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}